OBJECTIVE: Zonal organ allocation system comprises organ procurement by teams within a specific geographical area of each retrieval team. Therefore, in a substantial number of cases organs are retrieved by 'foreign' teams and are sent for transplantation to the implanting centre. The aim of this study was to assess the impact of zonal organ allocation system on early-and long-term outcomes after lung transplantation (LTx).
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INTRODUCTION
Donor organ procurement in cardiothoracic transplantation represents specialized and standardized procedures necessitating special training [1] . Particularly in the current era of using organs that fall outside standard acceptance criteria [2] [3] [4] , special expertise in management of such extended criteria donors became an indispensable quality of modern retrieval surgeons. Also, experience in various preservation strategies and modern organ perfusion techniques is essential for assessment and optimization of potentially transplantable organs [5, 6] . Until the early 1990s cardiothoracic transplant teams at each transplant centre in the UK were responsible for retrieving donor organs for transplantations performed at their centres. As off now such allocation logistics has represented national standards for thoracic organ retrieval in most European countries. In 1993, the NHS Blood and Transplant modified the UK national standard organ retrieval protocol following dividing the country in organ zones that were introduced to enable a more rational allocation system for donated organs. Each transplant centre became responsible for retrieving all organs from an identified zone in the country independent on the centre where the organ is scheduled for a transplant. Also, potential donor organs located in each zone are usually first offered to the 'local' centre. If an offer is turned down, donor lungs are allocated to other centres in a predetermined sequence. As standardized techniques and guidelines for lung procurement have been established, external retrieval teams are supposed to be able to successfully assess, optimize and procure donor lungs for other transplant centres. For lung transplantation (LTx) and organ procurement there are six certified centres in the UK: Birmingham, Newcastle, Manchester, Papworth, Harefield and Scotland [7] . However, it should be noted that Great Ormond Street is also involved in thoracic paediatric transplantation.
The idea behind the implementation of zonal allocation was to avoid long travel times, lower costs, optimize coordination processes of multiorgan and tissue retrievals and to develop the most appropriate allocation systems for patients in the UK [7, 8] . Despite these logistical and financial benefits there is unclear as to whether zonal allocation system has impact on early-and long-term outcomes. And this is not only about the experience of each retrieval team but more about the fact that colleagues who do not work together do not know each preferences, thresholds and limits. Particularly potential misunderstandings between implanting and 'foreign' retrieval surgeons in terms of providing information on results of organ assessment, quality of preservation, extent of organ damage, etc. may be crucial adversely impacting overall outcome after LTx.
Therefore, the aim of this study was to investigate the impact of zonal organ allocation comprising retrieval by external teams on early-and long-term outcomes after LTx. Importantly, potential confounders were excluded analysing propensity score matched, well-balanced groups with similar risk profiles.
MATERIALS AND METHODS
Organ procurement was performed by our institutional retrieval team compared with other teams from five designated lung transplant centres in the UK, within a specified geographical region of each centre. The Institutional Review Board at our centre approved this study and waived the need for individual patient consent. Patients with different risk profiles including recipients who were supported with extracorporeal membrane oxygenation (ECMO) and who underwent a redo transplantation were included in the study. The primary end-points were overall survival after LTx and freedom from bronchiolitis obliterans syndrome (BOS). Secondary end-points were perioperative clinical characteristics as well as adverse events which occurred over the follow-up. In order to control for selection bias and other confounders which might have an impact on outcomes, we performed a 1:1 propensity score matching based on preoperative variables which were significantly different or showed a trend between the two groups. Those matching variables included cardiopulmonary bypass strategy, type of donation [donation after cardiac death (DCD) versus donation after brain dead (DBD)], donor age, pO2 prior to retrieval, donor smoking history, total ischaemic time, recipient age, recipient diagnosis, need for preoperative ECMO and use of ex vivo lung perfusion (EVLP) or Organ Care System (OCS) Lung. Detailed donor data, such as demographic parameters, current clinical status, past medical history, radiological findings as well as functional donor organ status immediately before procurement were analysed. Also, demographics and preoperative recipient data as well as intraand postoperative variables were compared and adjusted in order to assess the differences in outcomes using organs retrieved by our institutional team and received from other national retrieval teams with similar donor/recipient risk profiles and surgical strategies.
Definitions
Total ischaemic time was defined as the time between cardiac arrest in DCD donors or aortic cross clamp in DBD donors and reperfusion of the second implanted lung. Lung function tests were performed on each hospital admission and transplant outpatient visit and BOS was diagnosed when post-transplant fraction of expired volume in 1 s (FEV 1 ) measured on the regularly basis after LTx permanently dropped >20% of the best FEV 1 achieved after LTx according to International Society for Heart and Lung Transplantation (ISHLT) recommendations [9] . The grade of primary graft dysfunction (PGD) was defined based on ISHLT Working Group on Primary Dysfunction Report. The pO 2 /FiO 2 ratio <200 was considered as PGD Grade 3 independent of findings on the chest X-ray [10] . Smoking history was defined as temporary or permanent smoking habit at the time of organ donation or in the past. One pack-year was defined as 20 cigarettes (one pack) smoked per day for 1 year. Extended donor criteria were defined as the pO 2 /FiO 2 ratio <300 (pO 2 measured in mmHg) and/or age over 55 years and/or history of smoking >20 pack-years.
Organ assessment and organ procurement protocol
Independent of the retrieval team donor organ assessment performed at donor hospitals always included radiological assessment, fibre-optic bronchoscopy, gross organ inspection and palpation, assessment of compliance using deflation test and selective blood-gas analysis from each pulmonary vein. The final decision of proceeding with organ procurement and transplantation was taken by the implanting surgeon after several conversations with the leading retrieval surgeon on the phone. The information provided to the implanting surgeon included results of the assessment and retrieval surgeon's overall impression of the organ to be procured. The standard preservation solution used by all was low potassium dextran (Perfadex, Medisan, Uppsala, Sweden) solution augmented with CaCl 2 , 3.6% tromethamine (THAM, HospiraInc, Lake Forest, IL, USA), and epoprostenol sodium 2.5 ml/l. For DBD donors, 4 l of the solution was usually administered antegradely and 1 l retrogradely. For DCD donors, 3 l of pneumoplegia was administered antegradely and 2 l retrogradely. During the pulmonary artery flush, a flushing pressure between 10 and 15 mmHg was maintained. Once the organs were removed from the chest, they were inspected and then packed for storage on ice and transported half inflated with FiO 2 0.5.
In the case of using the Organ Care System OCS Lung (Transmedics Inc, Boston, MA, USA), the system was set-up in the donor hospital in cases when our institutional team was involved in organ retrieval. Otherwise, in few cases OCS was used as EVLP in our centre after receiving organs retrieved by other teams.
Immunosuppression and anti-microbial treatment
Immunosuppression and anti-microbial treatment policies were equal for all patients independent of retrieval team. According to our institutional transplant guidelines, all patients received the same initial immunosuppression whereas the dose was adjusted according to target drug levels, and presence of infections or renal toxicity. Until October 2010 standard immunosuppression for lung transplant patients included ciclosporin, azathioprine and prednisolone. From October 2010 as off now, patients have received tacrolimus, mycophenolate mofetil and prednisolone.
Standard infection prophylaxis included valganciclovir for cytomegalovirus (CMV) and co-trimoxazole for pneumocystis prevention. No routine anti-fungal prophylaxis was given unless the recipient was known to be colonized with a fungal pathogen in which case a 6-week voriconazole treatment was commenced and adjusted according to voriconazole target levels. After that the treatment was continued according to patients' clinical response and radiological resolution of infective changes. Routine antibacterial prophylaxis was Piperacillin/ Tazobactam or other antibiotics according to sensitivities in sputum cultures during pretransplant follow-up.
Statistical analysis
All data were analysed using IBM SPSS Statistics for Windows, Version 21 (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY, USA) and are presented as continuous or categorical variables. Continuous data were evaluated for normality using one-sample Kolmogorov-Smirnov test and confirmed by histograms. Continuous variables were expressed as the mean ± standard deviation in cases of normal distributed variables or median (interquartile range) in cases of non-normal distributed variables. Categorical variables were presented as total numbers of patients and percentages. Continuous data were analysed with unpaired t-test for normally distributed variables and Mann-Whitney U-test for non-normally distributed variables. Pearson's v 2 or Fisher exact tests were used for categorical data dependent on the minimum expected count in each cross tab. Kaplan-Meier survival estimation was applied for survival analysis for recipients from both groups. Patients who survived at the cut off of the study were censored. Log Rank (Mantel-Cox) and Breslow (Generalized Wilcoxon) tests were applied for comparison of cumulative survival estimates. Propensity score matching function of SPSS software was conducted to reduce confounding bias between the groups. A propensity score for each patient was estimated using a logistic regression model with the group as the dependent variable and donor, preoperative and intraoperative characteristics which were statistically significant in overall comparison as independent variables. Matching was based on one-to-one nearest neighbour matching method with a tolerance level on the maximum propensity score distance (calipers of width 0.2 SD of the logit of the propensity score). This propensity score based matching procedure resulted in a total number of 238 donor and recipients, who were well matched for baseline characteristics. P-values <0.05 were considered statistically significant.
Results
We included data of 331 consecutive LTx which were performed at Harefield Hospital between January 2007 and January 2015. Recipients were divided into two groups depending on the organ retrieval team: 204 (61.6%) patients were transplanted using lungs retrieved by our institutional team (institutional team) and 127 patients (38.4%) by other teams (external team) from experienced transplant centres in the UK.
Propensity score matching
To minimize potential effects of selection bias and decrease variability of both groups, a propensity score matching was performed. The analysis was based on clinically relevant donor and recipient characteristics that significantly differ between the institutional and external groups analysing the entire patient cohort consisting of 331 patients.
A total number of 238 donors (119 in each group) and recipients remained for the analysis after matching. Of them, 9 (8%) vs 11 (9%) lungs were retrieved for single-lung transplantations by our institutional versus external teams, respectively. Two recipients (2%) from the institutional team group vs three (3%) from the external team group underwent retransplantation. In 22 (19%) cases lungs were procured by our team from Maastricht category III DCD donors and in 23 (19%) cases by other retrieval teams. The lungs were matched to the recipients according to blood group, height, total lung capacity, time on the waiting list and clinical status of the recipient at the time of transplantation.
Perioperative donor and recipient characteristics
As presented in Table 1 , after matching there were no statistically significant differences between the two groups in donor age (P = 0.74), gender (P = 0.24), cause of death (P = 0.74), smoking history (P = 0.90) as well as extent of smoking (P = 0.95), percentage of abnormal chest X-ray (P = 0.54), bronchoscopy (P = 0.78), duration of donor mechanical ventilation (P = 0.10) and last preretrieval pO2 (P = 0.27). Statistically and clinically there were no significant differences between the groups in terms of the use of ex vivo perfusion: 4% for our team and 7% for external teams for EVLP (P = 0.39), and 4% for our team and 3% for external teams for OCS (P = 1.00). Also, there was no difference in cold ischaemic storage time: 395 (275;470) min for our team and 369 (264;486) min for external teams (P = 0.94). Table 2 shows preoperative recipient demographics and distribution of recipient's diagnosis. There were no statistically significant differences in recipient's age (P = 0.80), gender (P = 0.90), height (P = 0.58), weight (P = 0.90) and preoperative use of extracorporeal life support (P = 0.76). Recipient diagnoses leading to indication for a lung transplant were also equally distributed between the two groups (P = 0.94).
Intraoperative variables and parameters of early postoperative outcome are presented in Table 3 . There were no statistically significant differences in terms of off-pump/onpump strategy (P = 0.98) and proportion of patients receiving a single-lung transplant (P = 0.64). The recipients from both groups had comparable postoperative pO 2 /FiO 2 ratios at the end of the transplant, at 24, 48 and 72 h. However, there was a trend towards higher incidence of PGD Grade 3 at 72 h postoperatively (P = 0.05) in recipients from the external team group. The incidence of the need for postoperative ECMO due to poor oxygenation was similar between the two groups (P = 0.54). The length of mechanical ventilation (P = 0.22), duration of ICU stay (P = 0.79) and total hospital stay (P = 0.83) were also similar in both groups.
Postoperative propensity score adjusted freedom from BOS over the 6-year follow-up was statistically poorer for external group (Fig. 1) : 93% vs 86% at 1 year, 93% vs 71% at 2 years, 75% vs 58% at 3 years, 66% vs 52% at 4 years, 55% vs 43% at 5 years, 55% vs 43% at 6 years, respectively (Log Rank P = 0.04). Overall cumulative survival estimated using Kaplan-Meier analysis over the 6-year follow-up was also poorer for the external retrieval team group; however, this difference did not reach statistical significance ( Fig. 2) : 92% vs 86% at 1 year, 84% vs 79% at 2 years, 76% vs 65% at 3 years, 66% vs 61% at 4 years, 67% vs 48% at 5 years, 67% vs 48% at 6 years, respectively (Log Rank P = 0.14). In order to assess individual centres associated with poorer freedom from BOS, a subgroup analysis was performed individually comparing results of four external retrieval teams with our institutional retrieval team (the fifth external retrieval team did not perform a sufficient number of retrievals for our centre that would justify a subgroup analysis). This analysis showed that long-term freedom from BOS was only significantly poorer in one of the four centres compared with our institution, whereas results from other centres were comparable or the difference did not reach statistical significance (Fig. 3) .
DISCUSSION
This article assesses the impact of zonal allocation system that has been applied in the UK for more than two decades on earlyand long-term outcomes after LTx. In order to prevent bias and to ensure that donor and recipient baseline characteristics in both groups are comparable, a 1:1 propensity score matching was performed. In order to eliminate potential bias, the groups were matched using objective donor and recipient baseline characteristics, despite the fact that the predictive value of the most donor variables is poor, whereas the recipient variables play an increasingly recognized role in determining outcomes [11] . Another variables that could have been included in the matching procedure are the number of centres that had declined lungs before they were offered to our institution and the reasons for rejecting lungs by those centres. However, such characteristics might not be objective and might not dispassionately describe donor organ quality. It is obvious that lungs turned down by other centres on logistics or lack of suitable recipient might be of good quality, whereas lungs declined on function are usually of poorer quality. However, it is not always the case as various centres and surgeons have various level of aggressiveness in terms of organ acceptance. That means that rejection of lungs on function by a less aggressive surgeon or centre cannot always mean that the lungs are of poor quality. This opinion can also be supported by increasing evidence suggesting extended criteria lungs to be transplantable with comparable results to standard criteria lungs [11] [12] [13] . Moreover, it is quite difficult to properly classify the reasons for rejection of lungs in functional versus non-functional category. There is no clear consensus in terms of what reason should be provided to NHSBT in cases when both functional and logistical/recipient aspects prohibit to accept lungs for a transplant. For that reason, a substantial proportion of poor lungs might be declined on logistics or lack of suitable recipients. On the other hand, good quality lungs might also be declined on function by a less aggressive surgeon as there is still no robust way to define donor lung quality [11] . The main finding of this study was that long-term freedom from BOS was significantly poorer in recipients who received organs retrieved by non-institutional teams. However, exact mechanisms of BOS development remain unclear, previous research shows that long-term survival is typically limited by BOS [9] . In the literature two different types of BOS are described: BOS with neutrophilic reversible allograft dysfunction and fibroproliferative BOS [14] . In either case an irreversible loss of lung function, after exclusion of other potential causes, and worsening in allograft function by the development of small airway narrowing, increasing dyspnoea and premature death represent characteristic clinical features of this syndrome [15, 16] . The registry of the ISHLT report showed that only 30% of patients surviving 10 years after LTx develop BOS [17] .
In terms of early postoperative results, both groups in general were statistically comparable. However, there was a trend towards higher incidence of PGD for recipients who received lungs retrieved by external teams. Though it did not reach statistical significance, it attracted our attention as there are several studies showing evidence that PGD is associated with an increased risk of short-term mortality [10, 18, 19] .
Previous research has been very sparse in assessing the impact of zonal allocation on outcomes in cardiothoracic transplantation. Aziz et al. [20] who analysed results of all cardiothoracic transplants performed between 1987 and 1998 showed that there was no difference in 30-day and 1-year survival after LTx among recipients who received local organs retrieved by their institutional team, distant organs retrieved by their institutional team and distant organs retrieved by other teams. Taking a look at the experience from the other continent, Shiraishi et al. [21] who investigated 159 consecutive LTx at their centre in the USA also showed no difference in terms of 30-day and 1-year survival. Although the results with up to 1 year of follow-up presented by both groups are similar to our results, no long-term follow-up and no analysis of BOS were presented by Aziz et al. and Shiraishi et al. Furthermore, the study by Aziz et al. was not specifically focused on LTx also analysing heart transplants, and a substantial proportion of recipients analysed were treated more than two decades ago. This is also important as logistical processes including organ transport, telecommunication, preservation strategies available, donor optimization and organ assessment have dramatically improved. Therefore, potential improvement in outcomes after transplants involving other teams for organ procurement might have been expected. Nevertheless, 1-year mortality of recipients transplanted using 'foreign' organs was similar, if not poorer, in our study comparing with the results presented in the 1990s. Also, overall long-term survival estimate in our study showed better cumulative survival using donor organs retrieved by our own institutional retrieval teams; however, it did not reach statistical significance. As it is well known that the major cause of late mortality remains BOS, we analysed freedom from BOS in long-term follow-up and found statistically better outcome of recipients who received organs retrieved by our institution. Although it might seem paradoxical at first sight, while early function is largely inseparable, there is a difference in late function. On the other hand, there was a trend towards higher incidence of PGD Grade 3 at 72 h postoperatively in recipients from the external team group with a P-value of 0.05 that is borderline to significance despite being limited by a relatively small number of patients and a single-centre cohort. Huang et al. [22] showed in their study that all grades of PGD at all time points are independent risk factors for BOS development and progression. Moreover, it was shown that PGD Grade 3 that was used in our study is associated with the highest relative risk of BOS accounting for 3.31. Therefore, there is an association between early PGD and development of BOS in our study, as both variables appeared to be of lower incidence when our institutional team retrieved donor lungs. Larger multicentre UK studies would be able to shed more light on this matter.
We presume that poor communication, lower level of trust, higher rate of misunderstandings due to possibly different views in assessing donor organs between external retrieval teams and implanting surgeon may adversely affect quality of organs resulting in inferior long-term outcome in LTx. Also, institutional teams are naturally involved in treatment of potential recipients on waiting lists regularly discussing their clinical condition and specific details that might help in decision-making process regarding suitability of donor organs for particular recipients.
Another reason for better results using organs retrieved by our team might be higher experience with assessment and optimization of marginal lungs for transplantation. According to the Annual Report on Cardiothoracic Transplantation (NHSBT report for 2014/2015) offer decline rates for bilateral offers and single lung offers at our centre compared with the national rate fall outside of the 99.8% confidence limits. This indicates that our institution had a significantly lower offer decline rate than the national average. Moreover, this analysis only considered those offers resulted in transplant. This aggressiveness in terms of organ acceptance has to be compensated by structured strategies in dealing with marginal donor lungs. Indeed, we adopted an aggressive policy of therapeutic manipulation of potential donors including in particular antibiotic therapy in suspected sepsis, close scrutiny and adaptation of fluid balance, increase in tidal volume and positive end expiratory pressure (PEEP), and bronchial toilet to remove secretions and reduce atelectasis.
Also, particularly in cases of extended criteria organs, description of the organ function on the phone might not always be structured and objective. Particularly in such situations it is often the case that the implanting surgeon not only wants to have numbers but also asks the retrieval surgeon about his opinion regarding the transplantability of the organ. Thus, discrepancies in centre aggressiveness might easily result in misunderstandings mentioned above. However, other potential reasons for worse long-term freedom from BOS should be elaborated in further studies: potential differences in organ assessment and optimization, procurement and preservation techniques.
Our findings are of high importance for the clinicians and centres involved in LTx as they show that despite potential benefits of the zonal allocation system, such as shorter travel times, lower costs and better coordination of retrievals, this system might not be optimal in terms of patient's long-term outcome. As there have been no studies looking into long-term results assessing zonal allocation in the UK or elsewhere in the world, our study is the first to provide criticism analysing the impact of the zonal allocation system. However, it remains unclear as to whether other centres would also have superior outcomes when donor lungs are retrieved by their institutional teams compared with teams from other centres. This should be clarified by further research to confirm our preliminary results. Thus, our findings need to be treated as tentative until more research is conducted to identify the role of zonal allocation system and its impact on overall survival and development of BOS.
Limitations
Our limitations include single centre setting and retrospective study design. The results of the two groups assessed in this study might be biased by other confounders. However, a propensity score matching was applied in order to minimize these biases.
CONCLUSION
Despite excellent early outcomes the zonal allocation system might be associated with significantly poorer long-term outcomes in terms of freedom from BOS after bilateral LTx. Further 
